- Home »
- Quarterly Results »
- Sanofi Consumer Healthcare India Q1 Results Profit After Tax Drops to ₹290 Million and Total Income at ₹1,652 Million
Sanofi Consumer Healthcare India Q1 Results Profit After Tax Drops to ₹290 Million and Total Income at ₹1,652 Million
Sanofi Consumer Healthcare India Q1 Results show a 22.9% QoQ decline in Total Income to ₹1,652 million, with Operating Profit at ₹208.90 Cr. and Profit After Tax down 53.7% QoQ, while the Operating Margin is 28.52%, Sanofi Consumer Healthcare India Q1 Results also report a 24% YoY increase in profit.
by P Nandhini
Updated Sep 14, 2024
Table of Content
Sanofi Consumer Healthcare India Q1 Results Live: Sanofi Consumer Healthcare India announced its Q1 results for FY 2024-2025 on August 13, 2024, showing a 5.2% quarter-on-quarter (QoQ) drop in total revenue, with total income for the quarter ending June 30, 2024, at ₹1,652 million, compared to ₹1,744 million in Q4 2023-2024.
The company's expenses saw a QoQ reduction as well, with a significant 19.3% decrease in the cost of materials consumed, bringing it down to ₹317 million from ₹393 million last quarter. Other expenses dropped to ₹305 million, marking a 34.4% drop in QoQ from ₹465 million in Q4.
On a year-over-year (YoY) basis, Sanofi Consumer Healthcare India experienced a 24% growth in profit, with profits rising to ₹290 million compared to ₹234 million in the same period last year. Employee benefits expenses rose slightly QoQ by 8.3%, reflecting growth in operational scale.
Depreciation and amortization also saw a QoQ increase of 22.2%, while finance costs remained minimal. Despite the drop in revenue QoQ, the company maintained strong profitability and continues to show resilience in the highly competitive pharmaceutical market.
For More Q1 results check our Twitter Page
Sanofi Consumer Healthcare India Q1 Results 2024 - 2025
Sanofi Consumer Healthcare India has announced its Q1 results for FY 2024-2025. The company experienced changes in revenue, expenses, and profitability on both a quarter-on-quarter (QoQ) and year-over-year (YoY) basis. Below is a summary of key financial metrics for the quarter ending June 30, 2024:
| Particulars | Q1 2024-2025 (₹ in Million) | Q4 2023-2024 (₹ in Million) | QoQ % Change |
|---|---|---|---|
| Revenue from Operations | 1,644 | 2,112 | -22.1% |
| Other Income | 8 | 30 | -73.3% |
| Total Income | 1,652 | 2,142 | -22.9% |
| Cost of Materials Consumed | 317 | 668 | -52.5% |
| Employee Benefits Expense | 248 | 229 | +8.3% |
| Other Expenses | 305 | 465 | -34.4% |
| Profit Before Tax | 389 | 839 | -53.6% |
| Profit After Tax | 290 | 627 | -53.7% |
| Earnings Per Share (EPS) (₹) | 12.58 | 27.24 | -53.8% |
Source: Click Here
Sanofi Consumer Healthcare India Current Market Overview
Sanofi Consumer Healthcare India is currently trading at ₹4,904 per share, with no recent change in price. The company's market value is ₹11,293 crore, reflecting its strong position in the healthcare sector. The stock has reached a high of ₹4,904 and a low of ₹4,479 in the past year.
Despite the solid market capitalization, the company does not offer dividends at the moment, and key financial metrics like P/E ratio, ROCE, and ROE are not available. This indicates a stable but cautious market outlook for the company.
| Particulars | Details |
|---|---|
| Current Price | ₹4,904 |
| Market Cap | ₹11,293 Cr. |
| 52-Week High | ₹4,904 |
| 52-Week Low | ₹4,479 |
| Dividend Yield | 0.00% |
| Face Value | ₹10.0 |
| BSE Code | 544250 |
| NSE Code | SANOFICONR |
Quarterly Results
Sanofi Consumer Healthcare India has released its quarterly results for the periods ending March 2024 and June 2024. The company saw a decrease in sales and profits from the previous quarter, with net profit falling by more than half. Below is a detailed comparison of key financial metrics for both quarters:
| Particulars | Mar 2024 (₹ in Million) | Jun 2024 (₹ in Million) |
|---|---|---|
| Sales | 211 | 164 |
| Expenses | 129 | 101 |
| Operating Profit | 82 | 64 |
| Operating Profit Margin (OPM %) | 39% | 39% |
| Other Income | 3 | -24 |
| Interest | 0 | 0 |
| Depreciation | 1 | 1 |
| Profit Before Tax | 84 | 39 |
| Tax % | 25% | 25% |
| Net Profit | 63 | 29 |
| Earnings Per Share (EPS in ₹) | — | 12.59 |
About Sanofi Consumer Healthcare India
Sanofi Consumer Healthcare India, established in 2023, is a part of the global pharmaceutical company Sanofi. It operates in the healthcare and pharmaceutical industry, focusing on providing high-quality consumer healthcare products.
With its registered office in Mumbai, the company aims to bring innovative healthcare solutions to the Indian market. Sanofi Consumer Healthcare India is committed to improving the well-being of people by offering over-the-counter medicines and healthcare products that cater to everyday health needs.
The company leverages Sanofi's global expertise while focusing on local market demands.
Check our website for more Q1 results.
Sanofi Consumer Healthcare India Q1 Results - FAQs
1. What is the latest revenue from operations for Sanofi Consumer Healthcare India?
The latest revenue from operations for Sanofi Consumer Healthcare India is ₹1,644 million.
2. When did Sanofi Consumer Healthcare India announce its Q1 results?
Sanofi Consumer Healthcare India announced its Q1 results on August 13, 2024.
3. What was the total income for Sanofi Consumer Healthcare India in Q1 2024?
The total income for Sanofi Consumer Healthcare India in Q1 2024 was ₹1,652 million.
4. What was the operating profit for Sanofi Consumer Healthcare India in Q1 2024?
The operating profit for Sanofi Consumer Healthcare India in Q1 2024 was ₹208.90 million.
5. What was the profit before tax for Sanofi Consumer Healthcare India in Q1 2024?
The profit before tax was ₹389 million in Q1 2024.
6. What was the profit after tax for Sanofi Consumer Healthcare India in Q1 2024?
The profit after tax was ₹290 million in Q1 2024.
7. What was the operating margin for Sanofi Consumer Healthcare India in Q1 2024?
The operating margin was 28.52% in Q1 2024.
8. What was the percentage drop in Sanofi Consumer Healthcare India's net profit in Q1 2024?
The net profit dropped by 53.7% in Q1 2024.
9. How did Sanofi Consumer Healthcare India's sales compare between March 2024 and June 2024?
Sales decreased from ₹211 million in March 2024 to ₹164 million in June 2024.
10. What was the tax percentage for Sanofi Consumer Healthcare India in Q1 2024?
The tax percentage was 25% in Q1 2024.